What Is Biomea Fusion, Inc. (BMEA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Biomea Fusion, Inc.'s intrinsic value is estimated at a composite fair value of $1.96. While the stock appears modestly undervalued at $1.29 (implied upside of +52.1%), our analysis suggests a thinner margin of safety across 6 of 9 bullish models. Notably, EROIC sees the most upside at +289.0% (fair value: $5.02), while Bayesian DCF is the most conservative at -31.3% ($0.89). The spread between these extremes — +320.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About BMEA?
9 of 13 models are currently active for BMEA. Of these, 6 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates BMEA's intrinsic value at $0.89, implying -31.3% downside from the current price. See which stocks rank higher →
How Does BMEA Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, BMEA ranks #294 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Biomea Fusion, Inc. operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating BMEA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is BMEA a Value Trap?
CirclFi's Value Trap algorithm assigns BMEA a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Biomea Fusion, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Biomea Fusion, Inc.'s fundamental quality profile registers 4.4/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +320.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BMEA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BMEA's 9 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad